Rhabdomyosarcoma is the commonest sarcoma in childhood, accounting for between 4 and 8% of malignant tumours in patients under 15 years of age (Sutow et al., 1984) . The most common histological type of childhood rhabdomyosarcoma is the embryonal variety. This consists mainly of small cells, with round to oval nuclei and little cytoplasm, and resemble the primitive mesenchymal stem cell from which the tumour is thought to arise (Enzinger & Weiss, 1983) .
By conventional histological and cytological techniques it is sometimes difficult to distinguish rhabdomyosarcomas from other 'small round cell tumours' of childhood, namely lymphoblastic leukaemia/lymphoma, neuroblastoma and Ewing's sarcoma (Reynolds et al., 1981; Triche & Askin, 1983) . Whilst it is relatively simple to differentiate neuroblastoma from lymphoblastic leukaemia/ lymphoma using panels of monoclonal antibodies, this is not the case for either Ewing's sarcoma or rhabdomyosarcoma (Kemshead et al., 1982) . Few in vitro cell lines are available to help in the search for new reagents that can selectively identify rhabdomyosarcomas from other 'small round cell' tumours of childhood (McAllister et al., 1969 (McAllister et al., , 1975 Giard et al., 1973) . We have systematically attempted to establish new rhabdomyosarcoma cell lines from biopsy and autopsy material. Here we describe one such cell line, JR-1, and demonstrate that both its morphological appearance and immunophenotype are analogous to the tissue from which it was derived.
Materials and methods

Case report
The JR-1 cell line was established from tumour material obtained at post mortem examination of a 7 year old girl. The patient first presented at the Hospital for Sick Children, Gt. Ormond Street, London, in May 1982, with a uterine neoplasm, following 2-3 weeks of abdominal pain. Biopsy revealed a tumour histologically classified as embryonal rhabdomyosarcoma, believed to have arisen from the left broad ligament. A computerised tomography scan showed metastatic spread of the tumour to the lungs. Following a regimen of radiotherapy with vincristine, cyclophosphamide and Actinomycin D, both the metastases and the primary pelvic mass were notably diminished. In January 1983 lung metastases of increasing size were again observed, and the patient died in May. Post mortem examination revealed a large, partially necrotic, mass of primary tumour filling the pevlis, and widespread, large metastases with no obvious necrosis in the lungs, liver, adrenal, kidneys, pancreas, rectum, bladder and peritoneum.
Histological assessment revealed the tumour to be a poorly differentiated embryonal rhabdomyosarcoma.
Establishment of the JR-I cell line
The tissue culture medium used throughout was RPMI 1640 medium, supplemented with 10% foetal calf serum (Gibco Europe Ltd.). 2mM glutamine (Gibco), 100IU penicillin (Gibco) and 100pgml-1 streptomycin (Gibco).
A specimen of tumour taken from a lung metastasis was washed in fresh medium and chopped into 2-3mm pieces. These were distributed between 25 cm2 plastic tissue culture flasks (Falcon) containing 5.0 ml of the above medium, and incubated at 37°C in a 5% CO2 incubator.
After 1 week, half the culture medium was replaced. Once sufficient cell growth had occurred complete medium changes were made 3 times a week. On confluency, cells were removed from the dishes using trypsin/versene and subcultured 1:3 into new culture flasks. Cultures were frozen at intervals in medium containing 10% foetal calf serum (FCS) (Figure 1 ). In addition a small number of large multinucleated cells are present -1.0%).
In this population nuclei vary in shape between round, oval and indented, and contain coarse chromatin and either very prominent single or multiple nucleoli (Figure 2A) . The Electron microscopy Electron microscopy of the JR-1 line shows rounded cells containing nuclei with granular chromatin, and an abundant cytoplasm rich in organelles (see Figure 2B ).
The cytoplasm contains many mitochondria and in some cells dilated cisternae are identified. In concordance with the PAS staining, seen by light microscopy, small numbers of cytoplasmic glycogen granules are identified together with free ribosomes a and rough endoplasmic reticulum. Thick and thin filaments are found in the majority of cells. These show a relationship characteristic of actin and myosin, both on longitudinal and transverse section. In some areas fibres appear condensed, as is seen in Z band formation ( Figure 2B ). There is no evidence of epithelial features. In particular, the cytoplasmic condensations lack the triplets of fused microtubules seen in the basal bodies of cilia.
Growth kinetics Cells taken at passage 44 and seeded into 15mm diameter dishes at an initial concentration of either 10 or 3 x 104 cells/well exhibited exponential growth with a doubling time of -29 h (data not presented). (Savage, 1975) were found in 10% of these cells.
G of the cells were shown to bind anti-desmin, whereas almost all cells bound an anti-vimentin monoclonal antibody (Table II) (Table III) .
Discussion
The pancity of human rhabdomyosarcoma cell lines described to date, reflects the rare occurrence of the tumour and the difficulty of establishing in vitro lines from childhood solid tumours. It is particularly important to establish cell lines of this tumour to investigate further its biology. Hopefully this will lead to an increase in the survival rate of children with this malignancy. The JR-1 cell line described in this report resembles, as far as we can determine, the tumour from which it was derived. In addition, the morphology of this cell line is similar to the previously published embryonal rhabdomyosarcoma derived lines RD618, TE441 and the rhabdomyosarcoma line RDi 14 (McAllister, 1972) . Of these, only JR-1 and RD618 show cytoplasmic banding following PTAH staining, a feature supporting their rhabdoid derivation.
Classification of tumours is possible by intermediate filament typing contrast, no binding was seen to rhabdomyosarcoma derived cell lines A673 or A204. Neither did A673 stain with antibody A2B5, or A204 with UJ13A. Despite JR-1 binding A2B5, UJ13A and other antibodies described as being 'neuroectodermal' in specificity, the line is unquestionably rhabdoid in nature. In addition to the data on rhabdomyoblast-specific cell surface and intracellular antigens (Tables 11-III) , particles and cytoplasmic banding are seen on PTAH staining (Figure 2 ). Electron microscopy also reveals thick and thin filaments and a tendency for Z bands to form (Figure 3 ). These are definitive criteria for the diagnosis of rhabdomyosarcoma (Toker, 1968) . In support of the proposed origin of JR-1, the clinical presentation of this tumour arising in the left broad ligament is not a recognised site of occurrence of neuroblastoma.
Evidence of the establishment of JR-1 as a cell line comes from continual growth of cells in culture (currently to passage 58) and the ability of cells to grow as a xenograft in nude mice (cells taken at passage 44).
Unfortunately G banding and karyotypes of JR-1 has not revealed a consistent chromosomal marker associated with the line. No consistent marker has been described in rhabdomyosarcoma in the past, although an increase in abberrations of chromosome 3 has been suggested as being linked with the malignancy. Despite culture for over 50 passages considerable variation in chromosome number persists within the line. Despite this variation, the growth rate determined between passages 32-50 has remained constant and the expression of cytoplasmic and cell membrane antigens within the cell line is relatively consistent from cell to cell. This suggests the heterogeneity in chromosomal number is due to the instability of near tetraploid cells, rather than due to several contaminating cell populations. Currently the line is being cloned to determine whether any stable variant can be established from the original culture. It is proposed that this in vitro cell line is suitable material for studying the biology of rare tumours such as rhabdomyosarcoma, as well as a source of cells which can legitimately be used as immunogen for raising and screening monoclonal antibodies to rhabdomyosarcoma.
